Trevi Therapeutics (TRVI) Debt to Equity (2020 - 2023)
Trevi Therapeutics' quarterly Debt to Equity came in at $0.07 in Q1 2023, down 94.53% year-on-year from $1.34 in Q1 2022, and down 13.64% quarter-over-quarter from $0.09 in Q4 2022.
Trevi Therapeutics has reported Debt to Equity for 4 years, with the latest figure at $0.07 in Q1 2023.
- For the quarter ending Q1 2023, Debt to Equity fell 94.53% year-over-year to $0.07; the trailing twelve-month figure through Mar 2023 stood at $0.07 (down 94.53% YoY), and the FY2022 full-year result was $0.09, down 89.96% from the prior year.
- Debt to Equity for Q1 2023 stood at $0.07, down from $0.09 in the prior quarter.
- The five-year high for Debt to Equity was $1.34 in Q1 2022, with the low at $0.07 in Q1 2023.
- Average Debt to Equity over 4 years is $0.56, with a median of $0.51 recorded in 2020.
- Year-over-year, Debt to Equity surged 225.01% in 2021 and sank 94.53% in 2023.
- Tracing TRVI's Debt to Equity over 4 years: stood at $0.51 in 2020, then jumped by 65.86% to $0.85 in 2021, then sank by 89.96% to $0.09 in 2022, then dropped by 13.64% to $0.07 in 2023.
- The last three Debt to Equity figures came in at $0.07 (Q1 2023), $0.09 (Q4 2022), and $0.1 (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.10 |
| Jun 30, 2022 | 0.21 |
| Mar 31, 2022 | 1.34 |
| Dec 31, 2021 | 0.85 |
| Sep 30, 2021 | 1.26 |
| Jun 30, 2021 | 0.80 |
| Mar 31, 2021 | 0.60 |
| Dec 31, 2020 | 0.51 |
| Sep 30, 2020 | 0.39 |